Acute gluten-induced inflammatory response highlights CCL20 as a potential biomarker for celiac disease
Gluten reintroduction triggers alterations in the inflammation-related protein profile of patients with CD. CCL20 emerges as a promising diagnostic candidate, its increase in plasma or serum, with low dependence on symptom presentation, may complement existing diagnostic approaches.
Authors
- Sara Gómez-Aguililla (ORCID: https://orcid.org/0000-0002-7525-1408)
- Beatriz Arau (ORCID: https://orcid.org/0000-0003-4099-505X)
- Carolina Sousa
- Concepción Núñez
- Natalia López-Palacios
- Mar Pujals
- Carla Senosiain
- Jorge Infante-Menéndez
- Sergio Farrais
- Ángela Ruiz-Carnicer
- Nuria González-López
- Fernando Fernández-Bañares
Institutions
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Unidad de Investigación en cuidados y servicios de salud (Investén-isciii) (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Mútua Terrassa (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
- Hospital Universitario Ramón y Cajal (ES)
- Universidad Autónoma de Madrid (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fimmu.2025.1745890
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III
- European Regional Development Fund